Celltrion Pharm Inc (068760) — Financial Flexibility Index
Celltrion Pharm Inc (068760) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of ₩25.71 Billion (operating CF ₩23.44 Billion minus capex ₩2.27 Billion) represents 0% of total liabilities (₩319.38 Billion). Check Celltrion Pharm Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Celltrion Pharm Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Celltrion Pharm Inc across 11 annual periods. For the full cash flow conversion analysis, see Celltrion Pharm Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Celltrion Pharm Inc (2014–2024)
Year-by-year free cash flow to debt coverage for Celltrion Pharm Inc. Explore debt repayment capacity of Celltrion Pharm Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.23x | ₩62.57 Billion | ₩56.59 Billion | ₩272.54 Billion | ▲ +288.6% |
| 2023 | 0.06x | ₩15.65 Billion | ₩8.76 Billion | ₩264.98 Billion | ▲ +540.8% |
| 2022 | 0.01x | ₩2.24 Billion | ₩-4.05 Billion | ₩242.94 Billion | ▼ -97.3% |
| 2021 | 0.35x | ₩105.65 Billion | ₩93.15 Billion | ₩305.92 Billion | ▲ +9.3% |
| 2020 | 0.32x | ₩78.22 Billion | ₩36.25 Billion | ₩247.51 Billion | ▲ +3.4% |
| 2019 | 0.31x | ₩58.34 Billion | ₩27.85 Billion | ₩190.95 Billion | ▲ +159.0% |
| 2018 | 0.12x | ₩21.52 Billion | ₩14.31 Billion | ₩182.41 Billion | ▲ +329.4% |
| 2017 | -0.05x | ₩-9.08 Billion | ₩-10.16 Billion | ₩176.65 Billion | ▲ +34.7% |
| 2016 | -0.08x | ₩-13.02 Billion | ₩-15.21 Billion | ₩165.37 Billion | ▼ -130.6% |
| 2015 | 0.26x | ₩59.33 Billion | ₩13.36 Billion | ₩230.54 Billion | ▲ +16.4% |
| 2014 | 0.22x | ₩43.48 Billion | ₩17.33 Billion | ₩196.74 Billion | — |